The use of subcutaneous scopolamine as a palliative treatment in Parkinson's disease

Palliative Medicine

Volumn 25, Issue 1, 2011, Pages 92-93

  Pérez, Laura Mónica ^a   Farriols, Cristina ^a   Puente, Victor ^a   Planas, Josep ^a   Ruiz, Inmaculada ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Intestinal obstruction; palliative care; Parkinson's disease; scopolamine; subcutaneous

Indexed keywords

CARBIDOPA; ENTACAPONE; LEVODOPA; SCOPOLAMINE;

AGED; ARTICLE; CARCINOMATOUS PERITONITIS; CASE REPORT; FEMALE; HUMAN; INTESTINE OBSTRUCTION; PALLIATIVE THERAPY; PARKINSON DISEASE; TERMINAL CARE; TREMOR; XEROSTOMIA;

AGED; CHOLINERGIC ANTAGONISTS; FEMALE; HUMANS; INFUSIONS, SUBCUTANEOUS; PALLIATIVE CARE; PARKINSON DISEASE; SCOPOLAMINE HYDROBROMIDE; TREMOR;

EID: 78751500867     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216310381662     Document Type: Article

References (10)

1. National Institute for Health and Clinical Excellence. Parkinson's Disease: Diagnosis and Management in Primary and Secondary Care. London: National Institute for Health and Clinical Excellence, 2006.
2. Hudson PL, Toye C. and Kristjanson LJ Would people with Parkinson's disease benefit from palliative care? Palliat Med 2006 ; 20: 87-94.
3. Harshaw WA History, progress, and current treatment of Parkinson's disease. 1817-2002. Available at: http://www.rafink.com/downloads/parktalk.doc (accessed 10 July 2010 ).
4. Poewe W. Treatments for Parkinson disease past achievements and current clinical needs. Neurology 2009 ; 72 (Suppl. 2). S65 - S73.
5. Brocks DR Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective. Pharm Pharmaceut Sci 1999 ; 2: 39-46.
6. Deleu D., Hanssens Y. and Northway MG Subcutaneous apomorphine: an evidence based review of its use in Parkinson's disease. Drugs Aging 2004 ; 21: 687-709.
7. Tyne HL, Parsons J., Sinnott A., Fox S., Fletcher N. and Steiger MJ A 10 year retrospective audit of long term apomorphine use in Parkinson's disease. J Neurol 2004 ; 251: 1370-1374.
8. Dewhurst F., Lee M. and Wood B. The pragmatic use of apomorphine at the end of life. Palliat Med 2009 ; 23: 777-779.
9. Sepulveda C., Marlin A., Yoshida T. and Ullrich A. Palliative care: the World Health Organization's global perspective. J Pain Symptom Manage 2002 ; 24: 91-96.
10. World Health Organization. WHO definition of palliative care. Available at: http://www.who.int/cancer/palliative/definition/en/ (accessed 10 July 2010 ).